| Are there differences between women’s and men’s antidepressant responses? FM Quitkin, JW Stewart, PJ McGrath, BP Taylor, MS Tisminetzky, ... American Journal of Psychiatry 159 (11), 1848-1854, 2002 | 190 | 2002 |
| When should a trial of fluoxetine for major depression be declared failed? FM Quitkin, E Petkova, PJ McGrath, B Taylor, C Beasley, J Stewart, ... American Journal of Psychiatry 160 (4), 734-740, 2003 | 145 | 2003 |
| Predictors of relapse in a prospective study of fluoxetine treatment of major depression PJ McGrath, JW Stewart, FM Quitkin, Y Chen, JE Alpert, AA Nierenberg, ... American Journal of Psychiatry 163 (9), 1542-1548, 2006 | 136 | 2006 |
| Does Attention Deficit Hyperactivity Disorder Increase the Risk of Suicide Attempts Agosti | 91 | 2011 |
| Association Between Progranulin and Gaucher Disease Jian | 89 | 2016 |
| Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder Papakostas | 63 | 2008 |
| Personal, behavioral, and environmental predictors of healthy weight maintenance during the transition to adulthood Larson | 50 | 2018 |
| The association between antidepressant treatment and brain connectivity in two double-blind, placebo-controlled clinical trials: a treatment mechanism study wang | 49 | 2019 |
| Combination Antidepressant Therapy for Major Depressive Disorder: Speed and Probability of Remission Stewart | 46 | 2014 |
| A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer C Blanco, JC Markowitz, DJ Hellerstein, AM Nezu, M Wall, M Olfson, ... Breast cancer research and treatment 173, 353-364, 2019 | 42 | 2019 |
| Behavioral activation therapy for return to work in medication-responsive chronic depression with persistent psychosocial dysfunction Hellerstein | 32 | 2015 |
| Disability Inclusion in Precision Medicine Research: A First National Survey Sabatello | 29 | 2019 |
| A Randomized Controlled Trial of Duloxetine VS. Placebo in the Treatment of Nonmajor Chronic Depression Hellerstein | 29 | 2012 |
| Neural mechanisms of expectancy-based placebo effects in antidepressant clinical trials Zilcha-Mano | 22 | 2019 |
| Increasing genomic literacy among adolescents Sabatello | 22 | 2019 |
| Chitinase-3-like protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher Disease Jian | 18 | 2018 |
| Residual sleep disturbance and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor … Yang | 16 | 2010 |
| Do Social Functioning and Symptoms Improve with Continuation Antidepressant Treatment of Persistent Depressive Disorder? An Observational Study Hellerstein | 14 | 2017 |
| Screening for depression with the PHQ-9 in young adults affected by HIV Mufson | 10 | 2021 |
| Including the Blind Community in Precision Medicine Research: Findings from A National Survey and Recommendations Sabatello | 9 | 2019 |
